and Stent Technology
Peripheral artery disease (PAD) has been treated percutaneously since 1964, when Charles Dotter and Melvin Judkins first described the technique of progressive serial dilatation of the arteries of the lower…
Peripheral artery disease (PAD) has been treated percutaneously since 1964, when Charles Dotter and Melvin Judkins first described the technique of progressive serial dilatation of the arteries of the lower…
An aneurysm has been traditionally defined as a localized dilation of an arterial segment by more than 50% of the reference diameter (1). Although more than 95% of the arterial…
Although accurate and thorough medical history taking and physical examination are crucial for diagnosing peripheral arterial disease (PAD), the limitations of clinical assessment necessitate adjunctive imaging techniques that improve the…
Venous thromboembolism, which comprises deep vein thrombosis (DVT) and pulmonary embolism (PE), is a leading cause of morbidity and mortality. In the United States, it is the third leading cause…
The last two decades have seen a dramatic increase in the number of endovascular procedures performed, due to expansion to treatment in all vascular territories and the use of novel…
INDICATIONS AND PIVOTAL TRIALS Natural History of Renal Artery Stenosis The prevalence of renal artery stenosis (RAS) in patients with hypertension (HTN) has been estimated at 1% to 5%; however,…
Central venous obstruction encompasses the varied disorders that result in the compression and occlusion of the venous structures in the chest. These include diseases related to the superior vena cava…
The first percutaneous vascular intervention was performed in the superficial femoral artery (SFA) by Charles Dotter in 1964 using a series of relatively crude dilatation devices. Despite the long-term…
The advancing field of percutaneous endovascular therapy has led to a significant increase in options available for the treatment of patients with symptomatic peripheral vascular disease. Previous reticence in applying…
Lower extremity peripheral arterial disease (PAD) affects 8 million people in the United States, with a prevalence of 29% (1), and is part of a spectrum of atherosclerotic disease that…